Cargando…
Exploring N-acyl-4-azatetracyclo[5.3.2.0(2,6).0(8,10)]dodec-11-enes as 11β-HSD1 Inhibitors
We recently found that a cyclohexanecarboxamide derived from 4-azatetracyclo[5.3.2.0(2,6).0(8,10)]dodec-11-ene displayed low nanomolar inhibition of 11β-HSD1. In continuation of our efforts to discover potent and selective 11β-HSD1 inhibitors, herein we explored several replacements for the cyclohex...
Autores principales: | Leiva, Rosana, McBride, Andrew, Binnie, Margaret, Webster, Scott P., Vázquez, Santiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017749/ https://www.ncbi.nlm.nih.gov/pubmed/29495550 http://dx.doi.org/10.3390/molecules23030536 |
Ejemplares similares
-
Syntheses and crystal structures of the anhydride 4-oxatetracyclo[5.3.2.0(2,6).0(8,10)]dodec-11-ene-3,5-dione and the related imide 4-(4-bromophenyl)-4-azatetracyclo[5.3.2.0(2,6).0(8,10)]dodec-11-ene-3,5-dione
por: Hulsman, Andrew, et al.
Publicado: (2020) -
2,2-Dichloro-3,7,7,11-tetramethyl-10-azatetracyclo[6.5.0.0(1,3).0(9,11)]tridecane
por: Oukhrib, Abdelouahd, et al.
Publicado: (2013) -
(1S,3R,8R,11S)-11-Bromo-10-bromomethyl-2,2-dichloro-3,7,7-trimethyltricyclo[6.4.0.0(1,3)]dodec-9-ene
por: Benharref, Ahmed, et al.
Publicado: (2013) -
9-Ethoxy-1,5,13-trimethyl-8,10-dioxatetracyclo[7.7.1.0(2,7).0(11,16)]heptadeca-2,4,6,11,13,15-hexaene
por: Nowakowska-Bogdan, Ewa Maria, et al.
Publicado: (2009) -
Selection and early clinical evaluation of the brain‐penetrant 11β‐hydroxysteroid dehydrogenase type 1 (11β‐HSD1) inhibitor UE2343 (Xanamem™)
por: Webster, Scott P, et al.
Publicado: (2017)